In the femoral neck , the mean BMD in the alendronate group increased by 2.07 % ( d = 0.014 ; 0.009 SE ) at 12 months , compared with a reduction of 1.87 % ( d = -0.014 ; 0.008 SE ) in the control group ( P = 0.046 ) .